News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Priaxon and Munich Technical University Hospital Announce Cooperation for the Development of Novel Anti-Infectives with Novel Mode of Action


11/8/2010 11:38:40 AM

MUNICH--(BUSINESS WIRE)--Priaxon AG, Munich, and the University Hospital Rechts der Isar (Technical University Munich) announce their cooperation for the development of new, highly selective anti-infective agents against a novel protein target class of widely spread infectious diseases. Their joint project is supported in the framework of the top cluster support project of the German Federal Ministry of Education and Research, coordinated by BioM GmbH. In the context of this top cluster support the Munich biotech region was awarded altogether EUR 40 mio., doubled by an additional amount of EUR 40 mio. in industry funding, and further raised by approx. EUR 12 mio. from the Free State of Bavaria, over a funding period of five years.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES